Skip to main content

[]

Intended for healthcare professionals
Skip to main content

Abstract

Background/Aims

Stepped-wedge cluster randomized trials tend to require fewer clusters than standard parallel-arm designs due to the switches between control and intervention conditions, but there are no recommendations for the minimum number of clusters. Trials randomizing an extremely small number of clusters are not uncommon, but the justification for small numbers of clusters is often unclear and appropriate analysis is often lacking. In addition, stepped-wedge cluster randomized trials are methodologically more complex due to their longitudinal correlation structure, and ignoring the distinct within- and between-period intracluster correlations can underestimate the sample size in small stepped-wedge cluster randomized trials. We conducted a review of published small stepped-wedge cluster randomized trials to understand how and why they are used, and to characterize approaches used in their design and analysis.

Methods

Electronic searches were used to identify primary reports of full-scale stepped-wedge cluster randomized trials published during the period 2016–2022; the subset that randomized two to six clusters was identified. Two reviewers independently extracted information from each report and any available protocol. Disagreements were resolved through discussion.

Results

We identified 61 stepped-wedge cluster randomized trials that randomized two to six clusters: median sample size (Q1–Q3) 1426 (420–7553) participants. Twelve (19.7%) gave some indication that the evaluation was considered a “preliminary” evaluation and 16 (26.2%) recognized the small number of clusters as a limitation. Sixteen (26.2%) provided an explanation for the limited number of clusters: the need to minimize contamination (e.g. by merging adjacent units), limited availability of clusters, and logistical considerations were common explanations. Majority (51, 83.6%) presented sample size or power calculations, but only one assumed distinct within- and between-period intracluster correlations. Few (10, 16.4%) utilized restricted randomization methods; more than half (34, 55.7%) identified baseline imbalances. The most common statistical method for analysis was the generalized linear mixed model (44, 72.1%). Only four trials (6.6%) reported statistical analyses considering small numbers of clusters: one used generalized estimating equations with small-sample correction, two used generalized linear mixed model with small-sample correction, and one used Bayesian analysis. Another eight (13.1%) used fixed-effects regression, the performance of which requires further evaluation under stepped-wedge cluster randomized trials with small numbers of clusters. None used permutation tests or cluster-period level analysis.

Conclusion

Methods appropriate for the design and analysis of small stepped-wedge cluster randomized trials have not been widely adopted in practice. Greater awareness is required that the use of standard sample size calculation methods can provide spuriously low numbers of required clusters. Methods such as generalized estimating equations or generalized linear mixed models with small-sample corrections, Bayesian approaches, and permutation tests may be more appropriate for the analysis of small stepped-wedge cluster randomized trials. Future research is needed to establish best practices for stepped-wedge cluster randomized trials with a small number of clusters.

Get full access to this article

View all access and purchase options for this article.

References

1. Hemming K, Haines TP, Chilton PJ, et al. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ 2015; 350: h391.
2. Lew RA, Miller CJ, Kim B, et al. A method to reduce imbalance for site-level randomized stepped wedge implementation trial designs. Implement Sci 2019; 14(1): 46.
3. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 2007; 28(2): 182–191.
4. Li F. Design and analysis considerations for cohort stepped wedge cluster randomized trials with a decay correlation structure. Stat Med 2020; 39(4): 438–455.
5. Li F, Hughes JP, Hemming K, et al. Mixed-effects models for the design and analysis of stepped wedge cluster randomized trials: an overview. Stat Methods Med Res 2021; 30(2): 612–639.
6. Nevins P, Davis-Plourde K, Pereira Macedo JA, et al. A scoping review described diversity in methods of randomization and reporting of baseline balance in stepped-wedge cluster randomized trials. J Clin Epidemiol 2023; 157: 134–145.
7. Nevins P, Ryan M, Davis-Plourde K, et al. Adherence to key recommendations for design and analysis of Stepped-Wedge Cluster Randomized Trials: a Review of trials published 2016-2022. Clin Trials 2024; 21(2): 199–210.
8. Hemming K, Taljaard M, Forbes A. Modeling clustering and treatment effect heterogeneity in parallel and stepped-wedge cluster randomized trials. Stat Med 2018; 37(6): 883–898.
9. Taljaard M, Teerenstra S, Ivers NM, et al. Substantial risks associated with few clusters in cluster randomized and stepped wedge designs. Clin Trials 2016; 13(4): 459–463.
10. Ford WP, Westgate PM. Maintaining the validity of inference in small-sample stepped wedge cluster randomized trials with binary outcomes when using generalized estimating equations. Stat Med 2020; 39(21): 2779–2792.
11. Barker D, McElduff P, D’Este C, et al. Stepped wedge cluster randomised trials: a review of the statistical methodology used and available. BMC Med Res Methodol 2016; 16(1): 69.
12. Prost A, Binik A, Abubakar I, et al. Logistic, ethical, and political dimensions of stepped wedge trials: critical review and case studies. Trials 2015; 16(1): 351.
13. Li F, Turner EL, Preisser JS. Sample size determination for GEE analyses of stepped wedge cluster randomized trials. Biometrics 2018; 74(4): 1450–1458.
14. Kahan BC, Forbes G, Ali Y, et al. Increased risk of type I errors in cluster randomised trials with small or medium numbers of clusters: a review, reanalysis, and simulation study. Trials 2016; 17(1): 438.
15. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997; 53(3): 983–997.
16. Kenward MG, Roger JH. An improved approximation to the precision of fixed effects from restricted maximum likelihood. Comput Stat Data Anal 2009; 53(7): 2583–2595.
17. Thompson J, Davey C, Hayes R, et al. Permutation tests for stepped-wedge cluster-randomized trials. Stata J Promot Commun Stat Stata 2019; 19(4): 803–819.
18. Wang R, De Gruttola V. The use of permutation tests for the analysis of parallel and stepped-wedge cluster-randomized trials. Stat Med 2017; 36(18): 2831–2843.
19. Thompson JA, Davey C, Fielding K, et al. Robust analysis of stepped wedge trials using cluster-level summaries within periods. Stat Med 2018; 37(16): 2487–2500.
20. Grantham KL, Kasza J, Heritier S, et al. Evaluating the performance of Bayesian and restricted maximum likelihood estimation for stepped wedge cluster randomized trials with a small number of clusters. BMC Med Res Methodol 2022; 22(1): 112.
21. Zhan D, Ouyang Y, Xu L, et al. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects. Clin Trials 2021; 18(3): 295–302.
22. Caille A, Taljaard M, Le Vilain-Abraham F, et al. Recruitment and implementation challenges were common in stepped-wedge cluster randomized trials: results from a methodological review. J Clin Epidemiol 2022; 148: 93–103.
23. Hemming K, Taljaard M, McKenzie JE, et al. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ 2018; 363: k1614.
24. Nevins P, Davis-Plourde K, Pereira Macedo J, et al. Handling of covariates in stepped-wedge cluster randomized trials: protocol for a methodological review, https://ruor.uottawa.ca/handle/10393/43901 (2022, accessed November 6, 2023).
25. Copas AJ, Lewis JJ, Thompson JA, et al. Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches. Trials 2015; 16(1): 352.
27. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, 2023, https://www.R-project.org/
28. Wright N, Ivers N, Eldridge S, et al. A review of the use of covariates in cluster randomized trials uncovers marked discrepancies between guidance and practice. J Clin Epidemiol 2015; 68(6): 603–609.
29. Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 1999; 28(2): 319–326.
30. Scott JM, deCamp A, Juraska M, et al. Finite-sample corrected gee of population average treatment effects in stepped wedge cluster randomized trials. Stat Methods Med Res 2017; 26(2): 583.
31. Li F, Yu H, Rathouz PJ, et al. Marginal modeling of cluster-period means and intraclass correlations in stepped wedge designs with binary outcomes. Biostatistics 2022; 23(3): 772–788.
32. Zhang Y, Preisser JS, Turner EL, et al. A general method for calculating power for GEE analysis of complete and incomplete stepped wedge cluster randomized trials. Stat Methods Med Res 2023; 32(1): 71–87.
33. Barker D, D’Este C, Campbell MJ, et al. Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: a simulation study. Trials 2017; 18(1): 119.
34. Lee KM, Ma X, Yang GM, et al. Inclusion of unexposed clusters improves the precision of fixed effects analysis of stepped-wedge cluster randomized trials. Stat Med 2022; 41(15): 2923–2938.
35. Hooper R, Teerenstra S, De Hoop E, et al. Sample size calculation for stepped wedge and other longitudinal cluster randomised trials. Stat Med 2016; 35(26): 4718–4728.
36. Rezaei-Darzi E, Kasza J, Forbes A, et al. Use of information criteria for selecting a correlation structure for longitudinal cluster randomised trials. Clin Trials 2022; 19(3): 316–325.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
Email Article Link
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published online: October 8, 2024
Issue published: February 2025

Keywords

  1. Systematic review
  2. stepped-wedge designs
  3. sample size and power calculation
  4. small number of clusters
  5. small-sample correction
  6. small stepped-wedge trials

Rights and permissions

© The Author(s) 2024.
Request permissions for this article.
PubMed: 39377196

Authors

Affiliations

Guangyu Tong
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, CT, USA
Pascale Nevins
Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
Department of Epidemiology and Biostatistics, Western University, London, ON, Canada
Mary Ryan
Department of Population Health Sciences, University of Wisconsin-Madison, Madison, WI, USA
Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA
Kendra Davis-Plourde
Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA
Yongdong Ouyang
Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
Jules Antoine Pereira Macedo
Université de Tours, Université de Nantes, INSERM, SPHERE U1246, Tours, France
Can Meng
Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA
Xueqi Wang
Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
Agnès Caille
Université de Tours, Université de Nantes, INSERM, SPHERE U1246, Tours, France
Inserm CIC 1415, CHRU de Tours, France
Fan Li
Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, CT, USA
Monica Taljaard
Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada

Notes

Guangyu Tong, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, 135 College Street, Suite 234, New Haven, CT 06510, USA. Email: [email protected]

Metrics and citations

Metrics

Journals metrics

This article was published in Clinical Trials.

View All Journal Metrics

Article usage*

Total views and downloads: 286

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 0

Crossref: 1

There are no citing articles to show.

Figures and tables

Figures & Media

Tables

View Options

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:

SCT members can access this journal content using society membership credentials.

SCT members can access this journal content using society membership credentials.


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text